- ICH GCP
- US Clinical Trials Registry
- Search trials
Clinical Trials Sponsored by Grifols Therapeutics Inc
Total 3041 results
-
Grifols Therapeutics LLCRecruitingBacterial Infections | B-cell Chronic Lymphocytic Leukemia | HypogammaglobulinemiaUnited States, Bulgaria, Poland, Romania, Serbia
-
Grifols Therapeutics LLCCompleted
-
Grifols Therapeutics LLCTerminatedCOVID-19 | Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) InfectionSpain
-
Grifols Therapeutics LLCCompleted
-
Grifols Therapeutics LLCCompletedAnti-Hepatitis A Antibody Levels in Heathy SubjectsUnited States
-
Grifols Therapeutics LLCCompletedAlpha₁-Antitrypsin DeficiencyUnited States
-
Grifols Therapeutics LLCCompletedPurpura, Thrombocytopenic, IdiopathicUnited States
-
Grifols Therapeutics LLCCompletedPrimary ImmunodeficiencyUnited States
-
Grifols Therapeutics LLCCompletedAlpha 1-Antitrypsin DeficiencyUnited States
-
Grifols Therapeutics LLCCompletedAlpha 1-Antitrypsin DeficiencyUnited States, United Kingdom
-
Grifols Therapeutics LLCInstituto Grifols, S.A.Recruiting
-
Instituto Grifols, S.A.TerminatedPost-polio SyndromeUnited States, Denmark, Spain, Germany, Poland, Canada, Czechia, Italy, Netherlands
-
Instituto Grifols, S.A.Completed
-
Grifols Therapeutics LLCInstituto Grifols, S.A.RecruitingAcute-On-Chronic Liver FailureUnited States, United Kingdom, Spain, Germany, Italy, Belgium, France, Austria, Denmark, Portugal
-
Grifols Therapeutics LLCGrifols Japan K.K.CompletedAlpha1-Antitrypsin DeficiencyJapan
-
Grifols Therapeutics LLCInstituto Grifols, S.A.CompletedCongenital AfibrinogenemiaIndia, United States, Italy, Lebanon
-
Grifols Therapeutics LLCActive, not recruitingPulmonary Emphysema in Alpha-1 PI DeficiencyUnited States, Australia, Denmark, New Zealand, Estonia, Poland, Russian Federation, Sweden, Brazil, Canada, France, Finland
-
Grifols Therapeutics LLCCompletedPrimary ImmunodeficiencySpain, France, Germany, United Kingdom, Australia, Czechia, Hungary, Poland, Sweden
-
Grifols Therapeutics LLCWithdrawnPrimary ImmunodeficiencyUnited States
-
Grifols Therapeutics LLCCompletedMyasthenia GravisUnited States, Belgium, Czechia, Estonia, Canada, France, Germany, Hungary, Poland, Lithuania
-
Grifols Therapeutics LLCCompletedPolyradiculoneuropathy, Chronic Inflammatory DemyelinatingUnited States, Israel, Germany, Czech Republic, Mexico, Argentina, Canada, Italy, Poland, Serbia
-
Grifols Therapeutics LLCCompleted
-
Grifols Therapeutics LLCCompletedAcute Ischemic StrokeSpain, Australia, France, Austria, Serbia, Slovakia
-
Grifols Therapeutics LLCCompleted
-
Grifols Therapeutics LLCCompleted
-
Grifols Therapeutics LLCCompletedEmphysema | Alpha 1-antitrypsin Deficiency (AATD)United States
-
Grifols Therapeutics LLCCompletedCommon Variable Immunodeficiency | Severe Combined Immunodeficiency | Wiskott-Aldrich Syndrome | Agammaglobulinemia | Immunologic Deficiency SyndromeCanada, United States
-
Grifols Therapeutics LLCRecruiting
-
Grifols Therapeutics LLCEnrolling by invitationPulmonary Emphysema in Alpha-1 Antitrypsin DeficiencyUnited States, New Zealand, Denmark, Australia, Finland, Estonia, Canada, Poland, Russian Federation, Sweden, France
-
Grifols Therapeutics LLCCompleted
-
Grifols Therapeutics LLCTerminatedCOVID-19United States, Brazil, Chile, Colombia, Mexico
-
Grifols Therapeutics LLCCompletedA Study to Assess the Efficacy and Safety of IGIV-C in Patients With Myasthenia Gravis ExacerbationsMyasthenia Gravis ExacerbationsBelgium, Poland, Canada, Argentina, Estonia, France, Hungary, Romania, Czechia, Latvia, Russian Federation, South Africa
-
Grifols Therapeutics LLCCompletedPrimary ImmunodeficiencyUnited States, Canada
-
Grifols Therapeutics LLCCompletedMyasthenia Gravis, GeneralizedUnited States, Belgium, Czechia, Canada, Estonia, Lithuania, France, Germany, Hungary, Poland
-
Grifols Therapeutics LLCTerminatedType 1 Diabetes MellitusUnited States
-
Grifols Therapeutics LLCCompletedAcute Peripheral Arterial OcclusionUnited States, Peru, Belgium, Bulgaria, Czech Republic, Germany, India, Poland, Romania, Serbia, Slovakia, Spain
-
Grifols Therapeutics LLCCompletedArterial Occlusive DiseasesUnited States
-
Grifols Therapeutics LLCCompletedMultiple Sclerosis, Relapsing-RemittingCanada, Israel, United States, Austria, Czech Republic, Germany, Greece, Hungary, Poland, Slovakia, Sweden, United Kingdom
-
Grifols Therapeutics LLCCompletedMacular DegenerationGermany
-
Grifols Therapeutics LLCTerminated
-
Grifols Therapeutics LLCCompletedImmunologic Deficiency SyndromeUnited States, Canada
-
Grifols Therapeutics LLCCompletedAlpha 1-Antitrypsin DeficiencyDenmark, Sweden, United Kingdom
-
Grifols Therapeutics LLCInstituto Grifols, S.A.Active, not recruitingDecompensated Cirrhosis and AscitesUnited States, Spain, Denmark, Belgium, Germany, Italy, Canada, Hungary, Poland, Bosnia and Herzegovina, Bulgaria, France, Serbia, United Kingdom
-
Instituto Grifols, S.A.WithdrawnHypofibrinogenemia | Congenital AfibrinogenemiaIndia, Turkey, Lebanon, United States, Bulgaria
-
Instituto Grifols, S.A.Instituto Grifols, S.A.CompletedExcessive Bleeding During SurgeryGermany, United States, Bulgaria, France, Hungary, Romania, Serbia, United Kingdom, Canada, Sweden
-
Grifols Therapeutics LLCGrifols Biologicals, LLCTerminatedHemophilia A, CongenitalUnited States, Spain, Italy, India, Canada, Russian Federation
-
Grifols Therapeutics LLCGrifols Japan K.K.Completed
-
Instituto Grifols, S.A.Completed
-
Grifols Therapeutics LLCGrifols Biologicals, LLCCompletedAmyotrophic Lateral SclerosisUnited States
-
Instituto Grifols, S.A.Completed